Le marché des organisations de recherche sous contrat DIV devrait atteindre 8 019,53 millions de dollars US d'ici 2028, contre 4 738,79 millions de dollars US en 2021 ; on estime qu'il augmentera à un TCAC de 7,8 % de 2021 à 2028.
Les organisations de recherche sous contrat IVD fournissent des services de soutien aux entreprises de biotechnologie tout au long du développement et de la commercialisation du produit. Les sociétés d'instruments/d'équipements de diagnostic ont besoin de divers services de réglementation et de test pour mettre en uvre le cycle de vie des produits. Les CRO sont spécifiquement conçus pour fournir ces services afin de réduire les coûts et le temps internes des entreprises. Le développement continu des établissements de santé et des produits IVD et les lancements de nouveaux produits propulsent la croissance du marché. En outre, la demande croissante d'avancées technologiques et de DIV basés sur des biomarqueurs en raison de plusieurs avantages qu'ils offrent favorise la croissance du marché. est segmenté en fonction du type, des services et de la géographie. Par géographie, le marché est largement segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale. Le rapport de marché offre des informations et une analyse approfondie du marché, en mettant l'accent sur des paramètres tels que les tendances du marché, les avancées technologiques, la dynamique du marché et l'analyse concurrentielle des principaux acteurs du marché mondial.
Régions lucratives pour le marché des organisations de recherche sous contrat IVD
Aperçus du marché Lancements de nouveaux produits par les acteurs du marché pour stimuler le marché des organisations de recherche sous contrat IVD pendant la période de prévision
La demande croissante de diagnostics in vitro est due à la prévalence croissante de diverses maladies, telles que le cancer, les maladies auto-immunes et les infections bactériennes. Ainsi, la demande de diagnostics in vitro efficaces et avancés pour détecter les maladies qui aident à traiter et à surveiller l'état des patients a augmenté. Divers acteurs du marché se concentrent sur l'offre de meilleurs produits de diagnostic in vitro pour répondre à la demande du marché, ce qui a conduit à l'augmentation des lancements de produits IVD. Cela a créé la demande d'organisations de recherche clinique IVD pour des études précliniques afin de garantir l'efficacité et l'exactitude des produits, stimulant ainsi la croissance du marché des organisations de recherche sous contrat IVD.
quelques exemples d'entreprises qui ont lancé de nouveaux produits et développements IVD :
- En février 2022, Invitae a annoncé la disponibilité de FusionPlex Dx et LiquidPlex Dx en Europe. Il fournit des produits CE-IVD de la plus haute qualité pour permettre aux pathologistes et aux oncologues européens de fournir efficacement des informations vitales à temps pour guider le traitement du cancer pour les patients. Il fournit une innovation essentielle de haute qualité pour l'oncologie de précision dans la lutte contre le cancer.
- En avril 2021, Illumina a annoncé la mise en place de ses efforts de détection du cancer en lançant un nouveau diagnostic in vitro (IVD) test pour renforcer ses collaborations en matière de diagnostic compagnon (CDx) axés sur l'oncologie. Il prévoit également de lancer une nouvelle plate-forme de données bioinformatiques basée sur le cloud.
De tels développements par les acteurs du marché stimulent le marché des organisations de recherche sous contrat IVD.
Type Insights
En fonction du type, le marché mondial des organisations de recherche sous contrat IVD est segmenté en chimie clinique, diagnostic moléculaire, immunochimie, diagnostic compagnon, hématologie, histologie et cytologie, microbiologie, et autres. En 2021, le segment de la chimie clinique détenait la plus grande part du marché. De plus, le segment de l'hématologie devrait enregistrer le TCAC le plus élevé du marché au cours de la période 2021-2028. La croissance du marché pour le segment de l'hématologie est attribuée à la sensibilisation accrue des patients, à l'auto-test des patients, au vieillissement rapide de la population mondiale et aux tests automatisés en raison des avancées technologiques. En outre, la demande croissante de DIV propulserait la croissance du marché dans les années à venir.
Marché des organisations de recherche sous contrat IVD, par type 2021 et 2028
Perspectives sur les services
Sur la base des services, le marché mondial des organisations de recherche sous contrat IVD est segmenté en recherche clinique, services de biostatistique et de gestion des données, expertise thérapeutique, services réglementaires , des services d'aide au remboursement, des services de développement d'essais et autres. En 2021, le segment des services de biostatistiques et de gestion de données détenait la plus grande part de marché. Cependant, le segment des services de soutien au remboursement devrait enregistrer le TCAC le plus élevé au cours de la période 2021-2028. La croissance du marché du segment des services de biostatistique et de gestion des données est attribuée à l'augmentation des essais cliniques, des études scientifiques fondamentales et de la recherche basée sur la population, ainsi qu'à leur conception, leur conduite, leur analyse et leur interprétation. Les outils de gestion des données de recherche clinique assistent toutes les parties de l'étude, de la configuration à la mise en uvre et à la soumission. Que les services de gestion des données cliniques soient requis en tant que service autonome, dans le cadre d'une offre de services complète ou en tant qu'externalisation fonctionnelle complète, les fournisseurs de services ont adapté les services de gestion des données cliniques pour répondre aux besoins. Ainsi, tous ces facteurs stimulent la croissance du marché des organisations de recherche sous contrat IVD.
Les lancements de produits et les collaborations sont des stratégies largement adoptées par les acteurs mondiaux du marché des organisations de recherche sous contrat IVD. Quelques-uns des développements clés récents du marché sont répertoriés ci-dessous :
- En mars 2022, NAMSA, une organisation de recherche sous contrat MedTech (CRO) leader mondial offrant des services de développement de bout en bout, a annoncé l'acquisition de ÅKRN Scientific Consulting, une importante CRO européenne de dispositifs médicaux basée à Madrid, en Espagne.
- En février 2022, Proxima Clinical Research, une société guidant les entreprises émergentes de dispositifs médicaux et pharmaceutiques depuis les premières étapes du développement du produit jusqu'à la commercialisation, ont annoncé qu'elles avaient reçu deux médailles d'or et une mention honorable par les AVA Digital Awards, un concours créatif international récompensant le génie créatif.
- En février 2021, Icon Plc a acquis PRA Health Sciences, Inc. Grâce à ces acquisitions, les deux entreprises peuvent apporter de la valeur à leurs patients, clients, personnel et actionnaires.
La pandémie de COVID-19 a eu un impact considérable sur l'organisation de recherche sous contrat DIV à l'échelle mondiale et a affecté les essais cliniques de divers produits. Les mutations constantes du nouveau coronavirus existant et sa gravité ont été la cause de pertes de vie catastrophiques et ont eu un impact sur l'économie mondiale. La pandémie de COVID-19 laisse perplexe les établissements de santé avec des défis opérationnels et cliniques sans précédent. La pandémie a eu un impact critique sur le monde, mais elle a également fourni une opportunité au marché des organisations de recherche sous contrat IVD. Les organisations de recherche sous contrat donnaient la priorité au développement de kits de test COVID-19, de traitements et de vaccins, ce qui a interrompu d'autres essais cliniques et activités de R&D. En outre, les initiatives gouvernementales de soutien et les investissements des principaux acteurs du marché dans le développement de kits de test COVID-19 basés sur IVD ont augmenté les essais cliniques pour les kits de test COVID-19 IVD. Une fois la pandémie maîtrisée, les essais cliniques pour d'autres diagnostics ainsi que les kits de test COVID-19 et sa production devraient favoriser la croissance du marché des organisations de recherche sous contrat IVD. Cependant, la pandémie de COVID-19 a conduit à la mise en uvre de nouvelles pratiques et approches avec des politiques réglementaires révisées pour les essais cliniques, ce qui devrait avoir un impact modérément positif sur le marché des organisations de recherche sous contrat IVD dans les années à venir.
Organisation de recherche sous contrat IVD - Segmentation du marché
Le marché mondial de l'organisation de recherche sous contrat IVD est segmenté en fonction du type, des services, et la géographie. En termes de type, le marché est segmenté en chimie clinique, diagnostic moléculaire, immunochimie, diagnostic compagnon, hématologie, histologie et cytologie, microbiologie, etc. Sur la base des services, le marché des organisations de recherche sous contrat IVD est segmenté en recherche clinique, services de biostatistique et de gestion de données, expertise thérapeutique, services réglementaires, services d'aide au remboursement, services de développement d'essais, etc. Géographiquement, le marché est segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale.
Profils des entreprises
- Proxima Clinical Research, Inc.
- Clinexa, ResearchDx
- NAMSA
- Nexelis, un Q² ; Solutions Company
- ICON PLC
- Toolbox Medical Innovations
- DCN Dx
- CMIC HOLDINGS Co., LTD
- AKRN Scientific Consulting SL
- ResearchDx
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
IVD Contract research organizations provide support services to the biotechnology, companies throughout the development and commercialization of the product. Diagnostic instruments/equipment companies require various regulatory as well as testing services to implement product lifecycle. CROs are specifically designed to perform these services in order to reduce the in-house cost and time of the companies.
Key factors that are driving the growth of this market are increasing demand for in-vitro diagnostics and clinical trials and new product launches by market players are expected to boost the market growth for the IVD contract research organizations over the years.
The CAGR value of the IVD contract research organizations market during the forecasted period of 2021-2028 is 7.8%.
The clinical chemistry segment held the largest share of the market in the global IVD contract research organizations market and held the largest market share of 23.99% in 2021.
The clinical research segment dominated the global IVD contract research organizations market and accounted for the largest market share of 19.21% in 2021.
The IVD contract research organizations market majorly consists of players such as Proxima Clinical Research, Inc.; Clinexa; ResearchDx; NAMSA; Nexelis, a Q² Solutions Company; ICON PLC; Toolbox Medical Innovations; DCN Dx; CMIC HOLDINGS Co., LTD and AKRN Scientific Consulting S.L. amongst others.
NAMSA and Proxima Clinical Research, Inc. are the top two companies that hold huge market shares in the IVD contract research organizations market.
North America IVD Contract Research Organizations market is segmented by country into US, Canada and Mexico. The US holds the largest share of the North American IVD contract research organization market. The growing innovations in the medical devices and diagnostics, increasing R&D activities, presence of well-established marketing hubs and increasing demand for various monitoring and therapeutic medical devices for IVD resulting in introduction of novel products likely to account for the growth of the market in the region.
The pandemic of coronavirus disease 2019 (COVID-19) has increased hospital resource use and necessitated the postponement of non-urgent heart surgical procedures. The market players have witnessed disruption in their business operations, slumped demand for products had marginal negative impact on the IVD contract research organizations market. Hence, the COVID 19 had somewhat negative impact on the IVD contract research organizations market before the introduction of COVID-19 vaccine. However, in the long run, as the vaccination schedule is established and the transmission rate decreases, healthcare systems will return to normal and is expected to experience increased demand for IVD contract research organizations.
The List of Companies - IVD Contract Reserach Organization Market
- Proxima Clinical Research, Inc.,
- Clinexa, ResearchDx
- NAMSA
- Nexelis, a Q² Solutions Company
- ICON PLC
- Toolbox Medical Innovations
- DCN Dx
- CMIC HOLDINGS Co., LTD
- AKRN Scientific Consulting S.L.
- ResearchDx
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2022
Emergency Call Systems Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Fall Prevention and Detection, Workflow Optimization, Patient Care Reminders, Alarms and Communication Management, Wander Management, Reporting and Analytics, Real-Time Staff Locating, and Others), End User (Hospital and Clinics, Assisted Living and Independent Living Facilities, Ambulatory Surgical Centers, and Others), Technology (Wired and Wireless), Offering (Hardware, Software, and Services), Product Type (Nurse Call Systems, Call Box Systems, Emergency Stanchions, Intercom System, and Others),, and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Outpatient Central Fulfillment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Automated Medication Dispensing Systems, Automated Packaging and Labeling Systems, Automated Tabletop Counters, Automated Storage and Retrieval Systems, and Others), End User (Hospital Pharmacies, Retail Pharmacies, and Mail-Order Pharmacies), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2022
Well-Being Platform Market
Forecast to 2030 - Global Analysis by Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Well-Being, and Others), Category (Fitness and Nutrition Consultant, Psychological Therapists, and Organizations/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations, and Home Use), and Geography
Mar 2022
Product Design and Development Services Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Services (Research, Strategy, and Concept Generation; Concept and Requirement Development; Detailed Design and Process Development; Process Validation, Manufacturing Transfer, and Design Validation; and Other Services), Application (Diagnostic Equipment, Therapeutic Equipment, Surgical Instruments, Clinical Laboratory Equipment, Biological Storage, Consumables, and Others), and End User (Medical Companies, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations)
Mar 2022
Patient Engagement Technology Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Component (Services, Hardware, and Software), Therapeutic Area (Fitness, Chronic Diseases, Women’s Health, and others), Delivery Mode (Cloud-Based and On-Premises), Application (Health Management, Financial Health Management, Home Healthcare Management, and Others), and End User (Patients, Payers, Providers, and Others)
Mar 2022
IVD Contract Research Organization Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Chemistry, Molecular Diagnostics, Immunochemistry, Companion Diagnostics, Hematology, Histology & Cytology, Microbiology, and Others), Services (Clinical Research, Biostatistics & Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography
Mar 2022
Dental CAD/CAM Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Dental CAD/CAM Materials (Glass Ceramics, Alumina-Based Ceramics, Lithium Disilicate, Zirconia, and Others) and Dental CAD/CAM Systems], Type (In-Office Systems and In-Lab Systems), Components [Hardware (Dental Printers, Milling Machines, Scanners, and Others) and Software], Application (Dental Prosthesis, Dental Implants, and Others), and End User (Dental Clinics, Dental Laboratories, Milling Centers, and Others)
Mar 2022
Emergency Medical Software Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Early Warning and Vulnerability Alert System (EWVAS), EMS Computer Aided Dispatch (CAD) System, Incident Response Software, Ambulance Management Software, and Others], Mode of Delivery [On Premises and Software as a Service (SaaS)], Platform (Android, iOS, Windows, and Others), and End User (Commercial, Municipal, State City Agencies, and Others)